DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,042 filers reported holding DANAHER CORPORATION in Q3 2023. The put-call ratio across all filers is 0.89 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $37,985,000 | +2.6% | 153,105 | -0.8% | 5.96% | -0.2% |
| Q2 2023 | $37,037,000 | -7.5% | 154,321 | -2.9% | 5.97% | -6.4% |
| Q1 2023 | $40,050,000 | -7.0% | 158,903 | -2.1% | 6.38% | -10.6% |
| Q4 2022 | $43,068,000 | +1.6% | 162,264 | -1.1% | 7.14% | -5.5% |
| Q3 2022 | $42,396,000 | +1.2% | 164,142 | -0.7% | 7.55% | +9.0% |
| Q2 2022 | $41,903,000 | -23.9% | 165,285 | -11.9% | 6.93% | -1.2% |
| Q1 2022 | $55,031,000 | -15.3% | 187,609 | -5.0% | 7.01% | +3.8% |
| Q4 2021 | $64,969,000 | +10.7% | 197,469 | +2.4% | 6.75% | +4.5% |
| Q3 2021 | $58,691,000 | +13.7% | 192,782 | +0.2% | 6.46% | +19.6% |
| Q2 2021 | $51,637,000 | +19.8% | 192,417 | +0.5% | 5.40% | +9.9% |
| Q1 2021 | $43,102,000 | +0.8% | 191,495 | -0.5% | 4.92% | -4.5% |
| Q4 2020 | $42,755,000 | +2.5% | 192,471 | -0.7% | 5.15% | -8.1% |
| Q3 2020 | $41,728,000 | +20.7% | 193,785 | -0.9% | 5.60% | +9.9% |
| Q2 2020 | $34,562,000 | -40.4% | 195,452 | -53.4% | 5.09% | -53.2% |
| Q1 2020 | $57,999,000 | -12.4% | 419,035 | -2.8% | 10.88% | +16.2% |
| Q4 2019 | $66,184,000 | +17.0% | 431,222 | +10.1% | 9.36% | -6.4% |
| Q3 2019 | $56,563,000 | -10.1% | 391,629 | -11.0% | 10.01% | +0.6% |
| Q2 2019 | $62,890,000 | +6.8% | 440,033 | -1.3% | 9.95% | +4.5% |
| Q1 2019 | $58,883,000 | +25.5% | 446,012 | -1.9% | 9.52% | +11.7% |
| Q4 2018 | $46,904,000 | -6.6% | 454,845 | -1.5% | 8.52% | +9.5% |
| Q3 2018 | $50,199,000 | +9.1% | 461,979 | -0.9% | 7.78% | +4.4% |
| Q2 2018 | $45,998,000 | +0.6% | 466,135 | -0.2% | 7.45% | -7.6% |
| Q1 2018 | $45,713,000 | +6.5% | 466,892 | +1.0% | 8.06% | +3.1% |
| Q4 2017 | $42,925,000 | +11.3% | 462,459 | +2.9% | 7.82% | +8.8% |
| Q3 2017 | $38,550,000 | -1.4% | 449,409 | -3.0% | 7.19% | -4.1% |
| Q2 2017 | $39,102,000 | +47.8% | 463,348 | +49.8% | 7.50% | +40.1% |
| Q1 2017 | $26,458,000 | +8.9% | 309,347 | -0.9% | 5.35% | +8.5% |
| Q4 2016 | $24,304,000 | -1.3% | 312,234 | -0.6% | 4.94% | -1.2% |
| Q3 2016 | $24,624,000 | -21.5% | 314,119 | +1.2% | 5.00% | -27.4% |
| Q2 2016 | $31,361,000 | +5.9% | 310,508 | -0.5% | 6.88% | +11.1% |
| Q1 2016 | $29,605,000 | -31.0% | 312,089 | -32.5% | 6.19% | -25.6% |
| Q4 2015 | $42,924,000 | +9.2% | 462,147 | +0.2% | 8.32% | -8.7% |
| Q3 2015 | $39,301,000 | -0.7% | 461,228 | -0.2% | 9.12% | +9.4% |
| Q2 2015 | $39,571,000 | -0.1% | 462,336 | -0.9% | 8.34% | +2.2% |
| Q1 2015 | $39,621,000 | -0.3% | 466,673 | +0.7% | 8.16% | +0.2% |
| Q4 2014 | $39,730,000 | +12.7% | 463,540 | -0.1% | 8.15% | -3.0% |
| Q3 2014 | $35,246,000 | -4.0% | 463,889 | -0.5% | 8.40% | +14.5% |
| Q2 2014 | $36,722,000 | +4.0% | 466,424 | -1.0% | 7.33% | +1.5% |
| Q1 2014 | $35,320,000 | -0.9% | 470,934 | +2.0% | 7.22% | -0.2% |
| Q4 2013 | $35,626,000 | -31.7% | 461,479 | -38.7% | 7.24% | -35.3% |
| Q3 2013 | $52,193,000 | +8.2% | 752,930 | -1.2% | 11.19% | +2.2% |
| Q2 2013 | $48,248,000 | – | 762,219 | – | 10.94% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
| Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
| CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
| Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
| GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
| DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
| CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
| Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
| Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
| GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |